PMID- 32862543
OWN - NLM
STAT- MEDLINE
DCOM- 20201116
LR  - 20201116
IS  - 1601-0825 (Electronic)
IS  - 1354-523X (Linking)
VI  - 26 Suppl 1
DP  - 2020 Sep
TI  - Clinical manifestations and risk factors for oral immune reconstitution 
      inflammatory syndrome in Mexico.
PG  - 153-157
LID - 10.1111/odi.13402 [doi]
AB  - The immune reconstitution inflammatory syndrome (IRIS) is a rare acute 
      complication presenting in people living with HIV (PLWH) within the first 
      6 months of starting combined antiretroviral therapy (cART). While there is 
      relevant information about its pathogenesis and clinical spectrum, IRIS-oral 
      lesions (IRIS-OLs) have been scarcely described. Thus, to establish the incidence 
      and clinical characteristics of IRIS-OLs, data from a cohort of 158 HIV 
      individuals starting cART, followed for 6 months, were obtained retrospectively. 
      IRIS-OLs developed in 11.4% of the individuals, in a median time of 87.5 days, 
      with oral candidiasis being the most frequent manifestation detected in eight 
      individuals (5.1%). The study emphasizes the importance of the correct diagnosis 
      and management of these lesions.
CI  - (c) 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights 
      reserved.
FAU - Castillejos-Garcia, Itzel
AU  - Castillejos-Garcia I
AD  - Oral Pathology and Medicine Master, Universidad Autonoma 
      Metropolitana-Xochimilco, Mexico City, Mexico.
FAU - Ramirez-Amador, Velia
AU  - Ramirez-Amador V
AD  - Oral Pathology and Medicine Master, Universidad Autonoma 
      Metropolitana-Xochimilco, Mexico City, Mexico.
FAU - Gomez-Mejia, Eduardo
AU  - Gomez-Mejia E
AD  - Oral Pathology and Medicine Master, Universidad Autonoma 
      Metropolitana-Xochimilco, Mexico City, Mexico.
FAU - Badial-Hernandez, Florentino
AU  - Badial-Hernandez F
AD  - Clinica Especializada Condesa, Mexico City, Mexico.
FAU - Anaya-Saavedra, Gabriela
AU  - Anaya-Saavedra G
AD  - Oral Pathology and Medicine Master, Universidad Autonoma 
      Metropolitana-Xochimilco, Mexico City, Mexico.
LA  - eng
PT  - Journal Article
PL  - Denmark
TA  - Oral Dis
JT  - Oral diseases
JID - 9508565
MH  - Antiretroviral Therapy, Highly Active/adverse effects
MH  - *HIV Infections/complications/drug therapy/epidemiology
MH  - Humans
MH  - *Immune Reconstitution Inflammatory Syndrome/epidemiology/etiology
MH  - Mexico/epidemiology
MH  - Retrospective Studies
MH  - Risk Factors
OTO - NOTNLM
OT  - HIV/AIDS
OT  - IRIS
OT  - oral lesions
EDAT- 2020/08/31 06:00
MHDA- 2020/11/18 06:00
CRDT- 2020/08/31 06:00
PHST- 2020/08/31 06:00 [entrez]
PHST- 2020/08/31 06:00 [pubmed]
PHST- 2020/11/18 06:00 [medline]
AID - 10.1111/odi.13402 [doi]
PST - ppublish
SO  - Oral Dis. 2020 Sep;26 Suppl 1:153-157. doi: 10.1111/odi.13402.